Table 1.
Total Cohort N=315 |
High HOMA-IR n=147 |
Normal HOMA-IR n=168 |
pa | |
---|---|---|---|---|
Demographics | ||||
Race (n; black)b | 159 | 95 | 64 | <0.001 |
Sex (n, female)b | 154 | 86 | 68 | 0.001 |
Age (years) | 11.3 ± 1.2 | 11.2 ± 1.3 | 11.5 ± 1.2 | 0.067 |
Sexual maturation stage | 2.4 ± 0.5 | 2.4 ± 0.5 | 2.3 ± 0.5 | 0.022 |
Anthropometrics | ||||
Height (cm) | 150.7 ± 9.3 | 151.5 ± 9.3 | 150.1 ± 9.3 | 0.175 |
Weight (kg) | 47.4 ± 12.1 | 52.1 ± 12.4 | 43.3 ± 10.3 | <0.001 |
BMI-for-age (percentile) | 68.2 ± 29.3 | 81.0 ± 21.5 | 57.0 ± 30.7 | <0.001 |
Tibia length (cm) | 35.0 ± 3.5 | 35.7 ± 3.2 | 34.3 ± 3.7 | <0.001 |
Body Composition | ||||
FFST (kg) | 30.5 ± 6.9 | 31.7 ± 6.4 | 29.3 ± 7.1 | 0.002 |
Fat mass (kg) | 14.7 ± 7.3 | 17.9 ± 8.0 | 11.9 ± 5.3 | <0.001 |
Percent body fat (%) | 31.0 ± 9.4 | 34.6 ± 9.5 | 27.9 ± 8.1 | <0.001 |
MCSA (mm2) | 4848.8 ± 1050.0 | 5071.4 ± 998.6 | 4655.7 ± 1058.1 | <0.001 |
Serum Biochemistries | ||||
Insulin (uU/mL) | 19.9 ± 10.1 | 27.3 ± 10.2 | 13.4 ± 3.3 | <0.001 |
Glucose (mg/dL) | 89.0 ± 7.1 | 91.3 ± 7.2 | 87.0 ± 6.5 | <0.001 |
HOMA-IR | 4.4 ± 2.4 | 6.2 ± 2.4 | 2.9 ± 0.7 | <0.001 |
IGF-I (ng/mL) | 232.4 ± 97.9 | 256.3 ± 107.3 | 211.5 ± 83.7 | <0.001 |
Cortical Bone | ||||
Ct.vBMD (mg/cm3) | 1062.6 ± 35.0 | 1066.7 ± 35.0 | 1059.1 ± 34.8 | 0.060 |
Ct.BMC (mg/mm) | 252.2 ± 47.8 | 262.0 ± 48.0 | 243.7 ± 46.1 | 0.001 |
Tt.Ar (mm2) | 446.6 ± 86.5 | 464.8 ± 87.2 | 430.8 ± 83.0 | 0.001 |
Ct.Ar (mm2) | 237.4 ± 44.5 | 245.4 ± 43.1 | 230.4 ± 44.5 | 0.003 |
Ct.Th (mm) | 3.8 ± 0.5 | 3.8 ± 0.5 | 3.7 ± 0.5 | 0.116 |
Peri.Circ (mm) | 74.6 ± 7.2 | 76.1 ± 7.2 | 73.3 ± 6.9 | 0.001 |
Endo.Circ (mm) | 50.9 ± 6.7 | 52.1 ± 6.9 | 49.8 ± 6.3 | 0.003 |
pSSI (mm3) | 1684.2 ± 467.0 | 1786.7 ± 475.9 | 1594.9 ± 441.5 | <0.001 |
Data are presented as mean ± standard deviation unless otherwise indicated
Test of between-group significance based on independent samples t-test
Test of between-group significance based on X-square test